// App-Quantinova.ai

3458 : Thrombosis and Risk of Mortality in Newly Diagnosed High-Risk Polycythemia Vera: An Analysis of the Medicare Claims Database in the United States

Researchers

Presenter

  • Naveen Pemmaraju

Principal Investigators

  • Aaron T. Gerds

  • Shreekant Parasuraman

  • Jingbo Yu

  • Anne Shah

  • Ann Xi

  • Shambhavi Kumar

  • Robyn M. Scherber

  • Srdan Verstovsek

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

  • Incyte Corporation, Wilmington, DE

  • Avalere Health LLC, Washington, DC

Locations

  • United States

Companies

  • Incyte Corporation

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Transient Ischemic Attack

  • Transient ischemic attack

  • Deep vein thrombosis

  • Pulmonary embolism

  • Polycythemia vera

  • Ischemic stroke

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved